Researchers recently presented data on the secondary endpoints of STEMI-DTU (ST-segment Elevation Myocardial Infarction ...
LCS 510(k) clearance sets stage for commercialization in the United States New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout 28% reduction in ...
At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results